Global Lipase Market - 2023-2030

Global Lipase Market - 2023-2030

Global Lipase Market reached US$ 729.12 million in 2022 and is expected to reach US$ 1209.41 billion by 2030, growing with a CAGR of 6.53% during the forecast period 2023-2030.

Growing awareness of health and wellness is driving the demand for specific dietary lipase products. Lipases are used in the production of low-fat and low-cholesterol food items. As more consumers seek healthier food choices, this trend is expected to continue influencing the lipase market positively. The clean-label and plant-based food movements are influencing the lipase market, prompting manufacturers to seek enzymes that align with these trends.

Europe is experiencing a surge in demand for clean-label products with natural ingredients. This trend is propelling the utilization of lipases as clean-label enzymes in food and beverage manufacturing. Manufacturers are seeking lipases from non-genetically modified organisms (non-GMO) and other natural sources to meet consumer preferences, expanding the market.

For instance, on November 8, 2022, DSM introduced four innovative solutions aimed at maximizing the performance of raw materials. One of these innovations, Panamore Xtense, was launched at FiE. This label-friendly lipase serves as a sustainable substitute for the commonly used emulsifier DATEM. It offers significant advantages to bread producers by enhancing dough stability and optimizing volume and shape.

Dynamics

Growing Demand for Processed Food

The rising consumption of processed foods is stimulating the need for enzymes like lipase in various stages of food processing. Lipase plays a role in breaking down fats into fatty acids and glycerol, making it indispensable in food manufacturing. Lipase helps food companies enhance the flavor profiles of processed foods. This is leading to the production of snacks and ready-to-eat meals with improved taste, making them more appealing to consumers.

Lipase is contributing to the development of food products with extended shelf life. By breaking down fats, it helps reduce rancidity and improves the longevity of processed food items, addressing a critical concern for both manufacturers and consumers. The food industry is witnessing a surge in the development of diverse processed food products, driving market growth.

Rising Health-Conscious Consumers

Health-conscious consumers are actively seeking out healthier food options. This trend drives the demand for lipase in the production of low-fat and low-calorie food products, aligning with dietary preferences are focusing on better nutrition and weight management. Lipase enzymes are used to reduce the fat content of processed foods without compromising taste. Health-conscious individuals prefer food items with lower fat content, which are factors driving market growth.

According to the Pancreatic Cancer Action Network, on July 5, 2022, the United States Food and Drug Administration (FDA) recommends that individuals begin with a dosage of 10,000 – 20,000 lipase units when consuming snacks and 20,000 – 40,000 lipase units with meals. Patients must adhere to the guideline of not surpassing 2,500 lipase units per kilogram of body weight per meal, assuming a total of four meals per day.

High Production Costs

High production costs in the lipase manufacturing process are leading to reduced profit margins for companies operating in the market. This limited profitability is hindering market growth, as it is constraining resources available for research and development, marketing, and expansion. High production costs often translate into higher prices for lipase-based products, restraining market growth.

The burden of high production costs is particularly challenging for small and medium-sized enterprises (SMEs) operating in the lipase market. These companies are facing difficulties in maintaining competitive pricing, which limits their market growth potential. High production costs are creating barriers for new entrants and startups looking to invest in the lipase market.

Segment Analysis

The global lipase market is segmented based on source, form, application, and region.

Growing Availability, Cost-Effectiveness, and Versatility of Microbial Lipase

The microbial segment held the largest share of the global lipase market. Microbial lipases are derived from microorganisms like bacteria and fungi. It is produced on a large scale, and this widespread availability ensures a stable supply for the market. Microbial lipases are a cost-effective choice for many industries. Their efficient production costs make them an attractive option for various applications.

Microbial lipases display versatility in their catalytic activities, making them suitable for a wide range of applications. This adaptability allows them to serve multiple sectors, such as food and biofuels. Manufacturers and researchers are focusing on enhancing the properties of microbial lipases to meet specific industrial needs. These tailored solutions cater to the diverse requirements of different applications.

Geographical Penetration

Robust Industrial Presence, Diverse Applications in Europe

Europe held the dominant position in the global lipase market. Europe has a strong, well-established food sector in countries such as Germany, France, and Italy, which is contributing significantly to the growth of the lipase market in the region. Europe is maintaining stringent quality and safety standards for the production and application of lipases in various sectors. This commitment to quality and compliance is enhancing the trust of consumers and industries in lipase products.

Lipase enzymes find applications in a wide range of sectors, from the food and pharmaceutical industries to biotechnology. The diversity of applications is allowing Europe to cater to a broad customer base. European companies are continually introducing innovative lipase products tailored to specific industry needs. This product innovation is helping them maintain a strong foothold in the market.

For instance, on May 29, 2020, Biocatalysts Ltd, specialists in enzymes, introduced its latest enzyme, Lipomod 767P. This non-genetically modified microbial lipase preparation is well-suited for both the hydrolysis and esterification of oils and fats. Its wide-ranging pH compatibility allows for use across various substrate types. Lipomod 767P offers the capability to selectively hydrolyze triglycerides, releasing free fatty acids.

COVID-19 Impact Analysis

The global lipase market faced supply chain disruptions due to lockdowns, restrictions, and transportation challenges, which have affected the timely availability of lipase products in the market. Lipase has applications in various end-user industries, including food, pharmaceuticals, and research. The disruptions in these sectors negatively affected the overall market as businesses scaled back production and research activities.

However, the lipase market experienced growth in the pharmaceutical sector as lipase enzymes played a role in potential treatments or vaccines for COVID-19. This led to increased research and development activities in the pharmaceutical market segment. The pandemic accelerated the adoption of e-commerce and home cooking. As a result, there was increased demand for lipase in consumer-friendly formats for baking and cooking, which benefited the market.

Russia-Ukraine War Impact Analysis

The lipase market has relied on a steady supply of raw materials. The geopolitical tension between Russia and Ukraine led to uncertainties in the sourcing of essential raw materials, which negatively impacted production. The lipase market experienced supply chain disruptions as the conflict disrupted transportation routes and logistics networks. This hampered the timely delivery of lipase products to various regions.

The conflict prompted greater emphasis on sustainability and self-sufficiency in various industries. This shift towards sustainability has driven innovation and growth in the lipase market as consumers and industries have sought more sustainable products. In response to the geopolitical tensions, players in the lipase market explored diversifying their supply sources to mitigate risks associated with dependency on specific regions.

By Source
• Microbial
• Animal
• Plant

By Form
• Liquid
• Powder

By Application
• Dairy
• Bakery and Confectionery
• Animal Feed
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Russia
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Key Developments
• On August 31, 2023, Alcresta Therapeutics, Inc., a prominent company specializing in the development and commercialization of innovative enzyme-based products, announced that the U.S. Food and Drug Administration (FDA) has granted clearance for the extended use of RELiZORB in children aged 2 to under 5 years. RELiZORB is a digestive enzyme cartridge designed to replicate the function of pancreatic lipase.
• On February 25, 2020, Researchers from the University of Portsmouth, in collaboration with an international team, created an enzyme derived from agricultural waste. This enzyme, produced from a by-product of mustard seeds, has the potential to become a valuable additive in laundry detergents. The aim is to develop an economical, naturally sourced alternative to lipase, the second most widely produced enzyme on the market.
• On December 18, 2023, Zomedica Corp. introduced three new assays – Canine Pancreatic Lipase (cPL), Cobalamin (B12), and Folate – for the TRUFORMA In-Clinic Biosensor Testing Platform.

Competitive Landscape

The major global players in the lipase market include Koninklijke DSM N.V., Novozymes A/S, Clerici-Sacco Group, Renco New Zealand, Enzyme Development Corporation, Chr. Hansen Holdings A/S, Amano Enzymes Inc., Associated British Foods PLC, International Flavors & Fragrances Inc., and Advanced Enzyme Tech.

Why Purchase the Report?
• To visualize the global lipase market segmentation based on source, form, application, and region, as well as understand critical commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous lipase market-level data points with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of critical products of all the major players.

The global lipase market report would provide approximately 61 tables, 57 figures, and 186 Pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies